Description: Wellfully Limited develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Australia. The company provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient; oral health; haircare solutions utilizing enhanced brushes and applicators; high penetration surface hygiene technologies; fabric and carpet cleaning technologies; and industrial surface interface systems. It offers various technology platforms, such as Static Micro-arrays, a film based micro-array technology for patches, masks, dressings, and other topical applications; and Field in Motion Micro-arrays, a magnetic micro-array film for use in brushes, applicators, and wipes; Dermaportation, a product development platform for a range of commercial applications; eSkin, a multi-product delivery system that offers a range of product-specific, time-varying magnetic fields for enhanced delivery of multiple formulations; and measured dose delivery devices and packaging solutions. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was founded in 2004 and is based in Leederville, Australia.
Home Page: www.wellfully.net
WFL Technical Analysis
Wells Fargo Funds Trust
,
Phone:
800-222-8222
Officers
Name | Title |
---|---|
Mr. Paul Peros | Exec. Chairman & CEO |
Mr. Jeffrey David Edwards | Founder, MD, Technical Director & Exec. Director |
Mr. Sergej Dolezil | Chief Financial Officer |
Dr. Matthew McIldowie | Chief Scientific Officer |
Mr. Henko Vos C.A. | Company Sec. |
Dr. Michael Roberts | Scientific Adviser |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 10.4833 |
Price-to-Sales TTM: | 2.375 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 0 |